If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marco Angelo Burgio is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

  • 3837 Citations
  • 10 h-Index
  • 33 Article
1 Citation (Scopus)

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

Antonia, S. J., Borghaei, H., Ramalingam, S. S., Horn, L., De Castro Carpeño, J., Pluzanski, A., Burgio, M. A., Garassino, M., Chow, L. Q. M., Gettinger, S., Crinò, L., Planchard, D., Butts, C., Drilon, A., Wojcik-Tomaszewska, J., Otterson, G. A., Agrawal, S., Li, A., Penrod, J. R. & Brahmer, J., Oct 2019, In : The Lancet Oncology. 20, 10, p. 1395-1408 14 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Survival
nivolumab
Safety

Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials

Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M. & 10 others, Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C. & Perrone, F., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2585-2592 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cisplatin
gemcitabine
Pemetrexed
Therapeutics

Cisplatin-based first-line treatment of elderly patients with advanced non-small-cell lung cancer: Joint analysis of MILES-3 and MILES-4 phase III trials

Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M. & 10 others, Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C. & Perrone, F., 2018, In : Journal of Clinical Oncology. 36, 25, p. 2585-2592 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer

Bronte, G., Bravaccini, S., Bronte, E., Burgio, M. A., Rolfo, C., Delmonte, A. & Crinò, L., Nov 1 2018, In : Biological Reviews. 93, 4, p. 1735-1746 12 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
lung neoplasms
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
66 Citations (Scopus)

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

Vokes, E. E., Ready, N., Felip, E., Horn, L., Burgio, M. A., Antonia, S. J., Frontera, O. A., Gettinger, S., Holgado, E., Spigel, D., Waterhouse, D., Domine, M., Garassino, M., Chow, L. Q. M., Blumenschein, G., Barlesi, F., Coudert, B., Gainor, J., Arrieta, O., Brahmer, J. & 6 others, Butts, C., Steins, M., Geese, W. J., Li, A., Healey, D. & Crinò, L., Apr 1 2018, In : Annals of Oncology. 29, 4, p. 959-965 7 p.

Research output: Contribution to journalArticle

docetaxel
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Liver
Survival